trial

Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample

NCTId NCT02800681
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 59 (actual)
Sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Primary completion 2018-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
59 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2016-06
Primary completion
2018-12
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
Expert panel evaluationSemi-structured psychopathological interviewsSelf-administered rating scalesOther general interviewer ratings

Sponsors

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalLead Sponsor
The Danish Autism CentreCollaborator

Investigators

2
Sidse Arnfred, MD, dr.med.Study Chair
Peter Handest, MD, Ph.d.Study Chair

Sites

2 total
Ballerup Municipality, DenmarkHerlev, Denmark

Facts & assertions

4 sourced
Enrollment
59
Phase
NA
Primary Completion Date
2018-12
Status
COMPLETED
relationships
The graph out of here
drug
Expert panel evaluation
drug
Semi-structured psychopathological interviews
drug
Self-administered rating scales
drug
Other general interviewer ratings
drug
lead_sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
company
collaborator
The Danish Autism Centre
company
indication
Asperger Syndrome
indication
Autism Spectrum Disorder
indication
Asperger Syndrome
indication
investigator
Sidse Arnfred, MD, dr.med.
person
Peter Handest, MD, Ph.d.
person